{"id":41748,"date":"2026-02-13T18:38:13","date_gmt":"2026-02-13T18:38:13","guid":{"rendered":"https:\/\/www.globalresearch.co.kr\/insight\/myasthenia-gravis-therapeutics-market-mordor\/"},"modified":"2026-10-02T18:16:02","modified_gmt":"2026-10-02T09:16:02","slug":"myasthenia-gravis-therapeutics-market-mordor","status":"publish","type":"post","link":"https:\/\/www.globalresearch.co.kr\/insight\/myasthenia-gravis-therapeutics-market-mordor\/","title":{"rendered":"\uc138\uacc4\uc758 \uc911\uc99d\uadfc\ubb34\ub825\uc99d \uce58\ub8cc\uc81c \uc2dc\uc7a5 \uaddc\ubaa8 \ubc0f \uc810\uc720\uc728 \ubd84\uc11d &#8211; \uc131\uc7a5 \ub3d9\ud5a5 \ubc0f \uc804\ub9dd (2026-2031)"},"content":{"rendered":"<p><img decoding=\"async\" src=\"https:\/\/www.globalresearch.co.kr\/insight\/wp-content\/uploads\/2026\/02\/myasthenia-gravis-therapeutics-market-1751354687493-major-players.webp\" alt=\"Chart\" class=\"aligncenter size-full\" \/><\/p>\n<p><img decoding=\"async\" src=\"https:\/\/www.globalresearch.co.kr\/insight\/wp-content\/uploads\/2026\/02\/myasthenia-gravis-therapeutics-market-size-image-1770823249446.webp\" alt=\"Chart\" class=\"aligncenter size-full\" \/><\/p>\n<p class=\"toc-level-1 toc-content-heading\" id=\"toc-content-heading-0\">1. \uc11c\ub860<\/p>\n<ul>\n<li class=\"toc-level-2\">1.1 \uc5f0\uad6c \uac00\uc815 \ubc0f \uc2dc\uc7a5 \uc815\uc758<\/li>\n<li class=\"toc-level-2\">1.2 \uc5f0\uad6c \ubc94\uc704<\/li>\n<\/ul>\n<p class=\"toc-level-1 toc-content-heading\" id=\"toc-content-heading-1\">2. \uc5f0\uad6c \ubc29\ubc95\ub860<\/p>\n<p class=\"toc-level-1 toc-content-heading\" id=\"toc-content-heading-2\">3. \uc694\uc57d<\/p>\n<p class=\"toc-level-1 toc-content-heading\" id=\"toc-content-heading-3\">4. \uc2dc\uc7a5 \ud658\uacbd<\/p>\n<ul>\n<li class=\"toc-level-2\">4.1 \uc2dc\uc7a5 \uac1c\uc694<\/li>\n<li class=\"toc-level-2\">4.2 \uc2dc\uc7a5 \ub3d9\uc778\n<ul>\n<li class=\"toc-level-3\">4.2.1 MG \ubc1c\ubcd1\ub960 \uc99d\uac00 \ubc0f \uc870\uae30 \uc9c4\ub2e8<\/li>\n<li class=\"toc-level-3\">4.2.2 \ubcf4\uccb4 \ubc0f FcRn \ud45c\uc801 \uc0dd\ubb3c\ud559\uc801 \uc81c\uc81c\uc758 \uc2b9\uc778 \uac00\uc18d\ud654<\/li>\n<li class=\"toc-level-3\">4.2.3 \ud76c\uadc0 \uc9c8\ud658 \uc778\uc13c\ud2f0\ube0c \ubc0f \ud504\ub9ac\ubbf8\uc5c4 \uac00\uaca9 \ucc45\uc815 \ud65c\uc6a9<\/li>\n<li class=\"toc-level-3\">4.2.4 \ubca4\ucc98\/\ub300\ud615 \uc81c\uc57d\uc0ac \uac70\ub798\ub85c \uc778\ud55c \uac15\ub825\ud55c \uc784\uc0c1 \uc2dc\ud5d8 \ud30c\uc774\ud504\ub77c\uc778<\/li>\n<li class=\"toc-level-3\">4.2.5 \uc790\uac00 \ud22c\uc5ec \ud53c\ud558 \uc0dd\ubb3c\ud559\uc801 \uc81c\uc81c\ub85c \uc21c\uc751\ub3c4 \ud5a5\uc0c1<\/li>\n<li class=\"toc-level-3\">4.2.6 AI \uae30\ubc18 \uadfc\uc804\ub3c4 \ubd84\uc11d\uc744 \ud1b5\ud55c \uc870\uae30 \uac1c\uc785 \uac00\ub2a5<\/li>\n<\/ul>\n<\/li>\n<li class=\"toc-level-2\">4.3 \uc2dc\uc7a5 \uc81c\uc57d\n<ul>\n<li class=\"toc-level-3\">4.3.1 \uc7a5\uae30 \uc0dd\ubb3c\ud559\uc801 \uc694\ubc95\uc758 \ub192\uc740 \ube44\uc6a9<\/li>\n<li class=\"toc-level-3\">4.3.2 \uc2e0\ud765 \uacbd\uc81c\uad6d\uc758 \ub0ae\uc740 \uc9c8\ubcd1 \uc778\uc2dd<\/li>\n<li class=\"toc-level-3\">4.3.3 \ub2e8\uc77c\ud074\ub860\ud56d\uccb4(mAbs)\uc758 \ucf5c\ub4dc\uccb4\uc778 \ubc0f \ubd84\uc11d QA \ubcf5\uc7a1\uc131<\/li>\n<li class=\"toc-level-3\">4.3.4 \uc194\ub9ac\ub9ac\uc2a4 \ud2b9\ud5c8 \ub9cc\ub8cc \ubc0f \ubc14\uc774\uc624\uc2dc\ubc00\ub7ec \uc9c4\uc785 \ud6c4 \uac00\uaca9 \ud558\ub77d \uc704\ud5d8<\/li>\n<\/ul>\n<\/li>\n<li class=\"toc-level-2\">4.4 \uac00\uce58 \/ \uacf5\uae09\ub9dd \ubd84\uc11d<\/li>\n<li class=\"toc-level-2\">4.5 \uaddc\uc81c \ud658\uacbd<\/li>\n<li class=\"toc-level-2\">4.6 \uae30\uc220 \uc804\ub9dd<\/li>\n<li class=\"toc-level-2\">4.7 \ud3ec\ud130\uc758 5\uac00\uc9c0 \uacbd\uc7c1 \uc694\uc778 \ubd84\uc11d\n<ul>\n<li class=\"toc-level-3\">4.7.1 \uacf5\uae09\uc5c5\uccb4\uc758 \uad50\uc12d\ub825<\/li>\n<li class=\"toc-level-3\">4.7.2 \uad6c\ub9e4\uc790\uc758 \uad50\uc12d\ub825<\/li>\n<li class=\"toc-level-3\">4.7.3 \uc2e0\uaddc \uc9c4\uc785\uc790\uc758 \uc704\ud611<\/li>\n<li class=\"toc-level-3\">4.7.4 \ub300\uccb4\uc7ac\uc758 \uc704\ud611<\/li>\n<li class=\"toc-level-3\">4.7.5 \uacbd\uc7c1 \uac15\ub3c4<\/li>\n<\/ul>\n<\/li>\n<\/ul>\n<p class=\"toc-level-1 toc-content-heading\" id=\"toc-content-heading-4\">5. \uc2dc\uc7a5 \uaddc\ubaa8 \ubc0f \uc131\uc7a5 \uc608\uce21 (\uac00\uce58-USD)<\/p>\n<ul>\n<li class=\"toc-level-2\">5.1 \uce58\ub8cc\ubc95\ubcc4\n<ul>\n<li class=\"toc-level-3\">5.1.1 \uc57d\ubb3c \uce58\ub8cc<\/li>\n<li class=\"toc-level-3\">5.1.2 \uc2e0\uc18d \uba74\uc5ed \uc694\ubc95<\/li>\n<li class=\"toc-level-4\">5.1.2.1 \uc815\ub9e5 \uba74\uc5ed\uae00\ub85c\ubd88\ub9b0 (IVIg)<\/li>\n<li class=\"toc-level-4\">5.1.2.2 \ud608\uc7a5 \uad50\ud658\uc220<\/li>\n<li class=\"toc-level-3\">5.1.3 \uc720\uc804\uc790 &amp; \uc138\ud3ec \uce58\ub8cc<\/li>\n<li class=\"toc-level-3\">5.1.4 \uae30\ud0c0 \uc2e0\ud765 \uce58\ub8cc\ubc95<\/li>\n<\/ul>\n<\/li>\n<li class=\"toc-level-2\">5.2 \ud22c\uc5ec \uacbd\ub85c\ubcc4\n<ul>\n<li class=\"toc-level-3\">5.2.1 \uacbd\uad6c<\/li>\n<li class=\"toc-level-3\">5.2.2 \uc815\ub9e5<\/li>\n<li class=\"toc-level-3\">5.2.3 \ud53c\ud558<\/li>\n<\/ul>\n<\/li>\n<li class=\"toc-level-2\">5.3 \uc57d\ubb3c \ubd84\ub958\ubcc4\n<ul>\n<li class=\"toc-level-3\">5.3.1 \ucf5c\ub9b0\uc5d0\uc2a4\ud14c\ub77c\uc81c \uc5b5\uc81c\uc81c<\/li>\n<li class=\"toc-level-3\">5.3.2 \ucf54\ub974\ud2f0\ucf54\uc2a4\ud14c\ub85c\uc774\ub4dc &amp; \uae30\ud0c0 \uba74\uc5ed\uc5b5\uc81c\uc81c<\/li>\n<li class=\"toc-level-3\">5.3.3 \ub2e8\uc77c\ud074\ub860 \ud56d\uccb4<\/li>\n<li class=\"toc-level-3\">5.3.4 \ubcf4\uccb4 \uc5b5\uc81c\uc81c<\/li>\n<li class=\"toc-level-3\">5.3.5 FcRn \uae38\ud56d\uc81c<\/li>\n<li class=\"toc-level-3\">5.3.6 \uae30\ud0c0<\/li>\n<\/ul>\n<\/li>\n<li class=\"toc-level-2\">5.4 \ucd5c\uc885 \uc0ac\uc6a9\uc790\ubcc4\n<ul>\n<li class=\"toc-level-3\">5.4.1 \ubcd1\uc6d0<\/li>\n<li class=\"toc-level-3\">5.4.2 \uc804\ubb38 \uc2e0\uacbd\uacfc \ud074\ub9ac\ub2c9<\/li>\n<li class=\"toc-level-3\">5.4.3 \uc7ac\ud0dd \uc758\ub8cc \ud658\uacbd<\/li>\n<li class=\"toc-level-3\">5.4.4 \uc678\ub798 \uc218\uc220 \uc13c\ud130<\/li>\n<\/ul>\n<\/li>\n<li class=\"toc-level-2\">5.5 \uc9c0\uc5ed\ubcc4\n<ul>\n<li class=\"toc-level-3\">5.5.1 \ubd81\ubbf8<\/li>\n<li class=\"toc-level-4\">5.5.1.1 \ubbf8\uad6d<\/li>\n<li class=\"toc-level-4\">5.5.1.2 \uce90\ub098\ub2e4<\/li>\n<li class=\"toc-level-4\">5.5.1.3 \uba55\uc2dc\ucf54<\/li>\n<li class=\"toc-level-3\">5.5.2 \uc720\ub7fd<\/li>\n<li class=\"toc-level-4\">5.5.2.1 \ub3c5\uc77c<\/li>\n<li class=\"toc-level-4\">5.5.2.2 \uc601\uad6d<\/li>\n<li class=\"toc-level-4\">5.5.2.3 \ud504\ub791\uc2a4<\/li>\n<li class=\"toc-level-4\">5.5.2.4 \uc774\ud0c8\ub9ac\uc544<\/li>\n<li class=\"toc-level-4\">5.5.2.5 \uc2a4\ud398\uc778<\/li>\n<li class=\"toc-level-4\">5.5.2.6 \uc720\ub7fd \uae30\ud0c0 \uc9c0\uc5ed<\/li>\n<li class=\"toc-level-3\">5.5.3 \uc544\uc2dc\uc544 \ud0dc\ud3c9\uc591<\/li>\n<li class=\"toc-level-4\">5.5.3.1 \uc911\uad6d<\/li>\n<li class=\"toc-level-4\">5.5.3.2 \uc77c\ubcf8<\/li>\n<li class=\"toc-level-4\">5.5.3.3 \uc778\ub3c4<\/li>\n<li class=\"toc-level-4\">5.5.3.4 \ud638\uc8fc<\/li>\n<li class=\"toc-level-4\">5.5.3.5 \ub300\ud55c\ubbfc\uad6d<\/li>\n<li class=\"toc-level-4\">5.5.3.6 \uc544\uc2dc\uc544 \ud0dc\ud3c9\uc591 \uae30\ud0c0 \uc9c0\uc5ed<\/li>\n<li class=\"toc-level-3\">5.5.4 \uc911\ub3d9 \ubc0f \uc544\ud504\ub9ac\uce74<\/li>\n<li class=\"toc-level-4\">5.5.4.1 GCC<\/li>\n<li class=\"toc-level-4\">5.5.4.2 \ub0a8\uc544\ud504\ub9ac\uce74<\/li>\n<li class=\"toc-level-4\">5.5.4.3 \uc911\ub3d9 \ubc0f \uc544\ud504\ub9ac\uce74 \uae30\ud0c0 \uc9c0\uc5ed<\/li>\n<li class=\"toc-level-3\">5.5.5 \ub0a8\ubbf8<\/li>\n<li class=\"toc-level-4\">5.5.5.1 \ube0c\ub77c\uc9c8<\/li>\n<li class=\"toc-level-4\">5.5.5.2 \uc544\ub974\ud5e8\ud2f0\ub098<\/li>\n<li class=\"toc-level-4\">5.5.5.3 \ub0a8\ubbf8 \uae30\ud0c0 \uc9c0\uc5ed<\/li>\n<\/ul>\n<\/li>\n<\/ul>\n<p class=\"toc-level-1 toc-content-heading\" id=\"toc-content-heading-5\">6. \uacbd\uc7c1 \ud658\uacbd<\/p>\n<ul>\n<li class=\"toc-level-2\">6.1 \uc2dc\uc7a5 \uc9d1\uc911\ub3c4<\/li>\n<li class=\"toc-level-2\">6.2 \uc2dc\uc7a5 \uc810\uc720\uc728 \ubd84\uc11d<\/li>\n<li class=\"toc-level-2\">6.3 \uae30\uc5c5 \ud504\ub85c\ud544 (\uae00\ub85c\ubc8c \uac1c\uc694, \uc2dc\uc7a5 \uac1c\uc694, \ud575\uc2ec \ubd80\ubb38, \uc7ac\ubb34 \uc815\ubcf4(\uc0ac\uc6a9 \uac00\ub2a5\ud55c \uacbd\uc6b0), \uc804\ub7b5 \uc815\ubcf4, \uc8fc\uc694 \uae30\uc5c5\uc758 \uc2dc\uc7a5 \uc21c\uc704\/\uc810\uc720\uc728, \uc81c\ud488 \ubc0f \uc11c\ube44\uc2a4, \ucd5c\uadfc \uac1c\ubc1c \ud3ec\ud568)\n<ul>\n<li class=\"toc-level-3\">6.3.1 AstraZeneca<\/li>\n<li class=\"toc-level-3\">6.3.2 argenx SE<\/li>\n<li class=\"toc-level-3\">6.3.3 UCB Pharma<\/li>\n<li class=\"toc-level-3\">6.3.4 Johnson &amp; Johnson (Janssen)<\/li>\n<li class=\"toc-level-3\">6.3.5 Novartis AG<\/li>\n<li class=\"toc-level-3\">6.3.6 Mitsubishi Tanabe Pharma<\/li>\n<li class=\"toc-level-3\">6.3.7 CSL Behring<\/li>\n<li class=\"toc-level-3\">6.3.8 Horizon Therapeutics<\/li>\n<li class=\"toc-level-3\">6.3.9 Immunovant Inc.<\/li>\n<li class=\"toc-level-3\">6.3.10 Regeneron Pharmaceuticals<\/li>\n<li class=\"toc-level-3\">6.3.11 F. Hoffmann-La Roche Ltd<\/li>\n<li class=\"toc-level-3\">6.3.12 Takeda Pharmaceutical<\/li>\n<li class=\"toc-level-3\">6.3.13 Astellas Pharma<\/li>\n<li class=\"toc-level-3\">6.3.14 Pfizer Inc.<\/li>\n<li class=\"toc-level-3\">6.3.15 CuraVac N.V.<\/li>\n<li class=\"toc-level-3\">6.3.16 Chugai Pharmaceutical<\/li>\n<li class=\"toc-level-3\">6.3.17 AbbVie Inc.<\/li>\n<li class=\"toc-level-3\">6.3.18 Grifols S.A.<\/li>\n<li class=\"toc-level-3\">6.3.19 Bausch Health<\/li>\n<\/ul>\n<\/li>\n<\/ul>\n<p class=\"toc-level-1 toc-content-heading\" id=\"toc-content-heading-6\">7. \uc2dc\uc7a5 \uae30\ud68c \ubc0f \ubbf8\ub798 \uc804\ub9dd<\/p>\n","protected":false},"excerpt":{"rendered":"<p>\uc911\uc99d\uadfc\ubb34\ub825\uc99d \uce58\ub8cc\uc81c \uc2dc\uc7a5 \uac1c\uc694 (2026-2031)<\/p>\n<p>\ubcf8 \ubcf4\uace0\uc11c\ub294 \uc911\uc99d\uadfc\ubb34\ub825\uc99d(Myasthenia Gravis, MG) \uce58\ub8cc\uc81c \uc2dc\uc7a5\uc758 \uaddc\ubaa8, \ub3d9\ud5a5 \ubc0f \uc810\uc720\uc728\uc744 2031\ub144\uae4c\uc9c0 \uc804\ub9dd\ud558\uba70, \uce58\ub8cc\ubc95, \ud22c\uc5ec \uacbd\ub85c, \uc57d\ubb3c \ubd84\ub958, \ucd5c\uc885 \uc0ac\uc6a9\uc790 \ubc0f \uc9c0\uc5ed\ubcc4\ub85c \uc2dc\uc7a5\uc744 \uc138\ubd84\ud654\ud558\uc5ec \ubd84\uc11d\ud569\ub2c8\ub2e4. \uc2dc\uc7a5 \uc608\uce21\uc740 \uac00\uce58(USD)\ub97c \uae30\uc900\uc73c\ub85c \uc81c\uacf5\ub429\ub2c8\ub2e4.<\/p>\n<p>\uc2dc\uc7a5 \uaddc\ubaa8 \ubc0f \uc131\uc7a5 \uc804\ub9dd:<\/p>\n<p>\uc911\uc99d\uadfc\ubb34\ub825\uc99d \uce58\ub8cc\uc81c \uc2dc\uc7a5\uc740 2026\ub144 21\uc5b5 8\ucc9c\ub9cc \ub2ec\ub7ec\ub85c \ucd94\uc815\ub418\uba70, 2025\ub144 20\uc5b5 2\ucc9c\ub9cc \ub2ec\ub7ec\uc5d0\uc11c \uc131\uc7a5\ud558\uc5ec 2031\ub144\uc5d0\ub294 31\uc5b5 7\ucc9c\ub9cc \ub2ec\ub7ec\uc5d0 \ub2ec\ud560 \uac83\uc73c\ub85c \uc804\ub9dd\ub429\ub2c8\ub2e4. \uc774\ub294 2026\ub144\ubd80\ud130 2031\ub144\uae4c\uc9c0 \uc5f0\ud3c9\uade0 \uc131\uc7a5\ub960(CAGR) 7.82%\ub97c \uae30\ub85d\ud560 \uac83\uc73c\ub85c \uc608\uc0c1\ub429\ub2c8\ub2e4. \uc544\uc2dc\uc544 \ud0dc\ud3c9\uc591 \uc9c0\uc5ed\uc774 \uac00\uc7a5 \ube60\ub974\uac8c \uc131\uc7a5\ud558\ub294 \uc2dc\uc7a5\uc774\uba70, \ubd81\ubbf8\uac00 \uac00\uc7a5 \ud070 \uc2dc\uc7a5 \uc810\uc720\uc728\uc744 \ucc28\uc9c0\ud558\uace0 \uc788\uc2b5\ub2c8\ub2e4. \uc2dc\uc7a5 \uc9d1\uc911\ub3c4\ub294 \uc911\uac04 \uc218\uc900\uc785\ub2c8\ub2e4.<\/p>\n<p>\uc2dc\uc7a5 \ubd84\uc11d \ubc0f \uc8fc\uc694 \ub3d9\ud5a5:<\/p>\n<p>FcRn \uae38\ud56d\uc81c \ubc0f \ubcf4\uccb4 \uc5b5\uc81c\uc81c\uc640 \uac19\uc740 \uc0dd\ubb3c\ud559\uc801 \uc81c\uc81c\uc758 \ucc44\ud0dd \uc99d\uac00\ub294 \uce58\ub8cc \uacbd\ub85c\ub97c \uc7ac\uc815\uc758\ud558\uace0 \uc788\uc73c\uba70, \uc9c0\ubd88\uc790(payer)\ub4e4\uc774 \uc0c1\ud658 \ud504\ub808\uc784\uc6cc\ud06c\ub97c \uc7ac\ud3c9\uac00\ud558\ub3c4\ub85d \uc720\ub3c4\ud558\uace0 \uc788\uc2b5\ub2c8\ub2e4. \ud30c\uc774\ud504\ub77c\uc778\uc758 \uc131\uc219, \ud76c\uadc0\uc758\uc57d\ud488 \uc778\uc13c\ud2f0\ube0c \ubc0f \ubca4\ucc98 \ud22c\uc790 \ud611\ub825\uc740 \uac1c\ubc1c \uc8fc\uae30\ub97c \ub2e8\ucd95\uc2dc\ucf30\uace0, \ud53c\ud558(SC) \uc81c\ud615\uc740 \uce58\ub8cc \ubd84\uc0b0\ud654\ub97c \uac00\uc18d\ud654\ud558\uace0 \uc788\uc2b5\ub2c8\ub2e4. \ub192\uc740 \uc720\ubcd1\ub960 \uc99d\uac00, AI \uae30\ubc18 \ub3c4\uad6c\ub97c \ud1b5\ud55c \uc870\uae30 \uc9c4\ub2e8, \uadf8\ub9ac\uace0 \ud504\ub9ac\ubbf8\uc5c4 \uac00\uaca9 \ucc45\uc815\uc758 \uc720\uc5f0\uc131\uc740 \uc218\uc775 \uc804\ub9dd\uc744 \ub354\uc6b1 \uac15\ud654\ud569\ub2c8\ub2e4. \uc874\uc2a8\uc564\ub4dc\uc874\uc2a8(Johnson &#038; Johnson), \uc544\ub974\uc820\uc5d1\uc2a4(argenx), UCB\uac00 \uc2e0\uc81c\ud488 \ucd9c\uc2dc\ub97c \ud655\ub300\ud558\uace0 2030\ub144 \uc774\ud6c4 \ubc14\uc774\uc624\uc2dc\ubc00\ub7ec \ud504\ub85c\uadf8\ub7a8\uc774 \uc9c4\uc785\uc744 \uc900\ube44\ud568\uc5d0 \ub530\ub77c \uacbd\uc7c1 \uac15\ub3c4\ub294 \ub354\uc6b1 \uc2ec\ud654\ub420 \uac83\uc73c\ub85c \uc608\uc0c1\ub429\ub2c8\ub2e4.<\/p>\n<p>\uc8fc\uc694 \ubcf4\uace0\uc11c \uc694\uc57d:<\/p>\n<p>*   \uce58\ub8cc\ubc95: \uc57d\ubb3c \uce58\ub8cc\uac00 2025\ub144 \ub9e4\ucd9c\uc758 68.74%\ub97c \ucc28\uc9c0\ud558\uba70 \uc120\ub450\ub97c \ub2ec\ub838\uace0, \uc720\uc804\uc790 \ubc0f \uc138\ud3ec \uce58\ub8cc\ubc95\uc740 2031\ub144\uae4c\uc9c0 \uc5f0\ud3c9\uade0 9.41%\uc758 \uc131\uc7a5\ub960\uc744 \ubcf4\uc774\uba70 \ud655\uc7a5\ub418\uace0 \uc788\uc2b5\ub2c8\ub2e4.<br \/>\n*   \ud22c\uc5ec \uacbd\ub85c: \uc815\ub9e5 \uc8fc\uc0ac(IV)\uac00 2025\ub144 \uc2dc\uc7a5 \uc810\uc720\uc728\uc758 62.90%\ub97c \ucc28\uc9c0\ud588\uc73c\ub098, \ud53c\ud558(SC) \ud22c\uc5ec\ub294 2031\ub144\uae4c\uc9c0 \uc5f0\ud3c9\uade0 9.85%\ub85c \ube60\ub974\uac8c \uc131\uc7a5\ud558\uace0 \uc788\uc2b5\ub2c8\ub2e4.<br \/>\n*   \uc57d\ubb3c \ubd84\ub958: \ucf5c\ub9b0\uc5d0\uc2a4\ud14c\ub77c\uc81c \uc5b5\uc81c\uc81c\uac00 2025\ub144 \uc2dc\uc7a5 \uaddc\ubaa8\uc758 45.98%\ub97c \ucc28\uc9c0\ud588\uc73c\uba70, \ub2e8\uc77c\ud074\ub860\ud56d\uccb4\ub294 2031\ub144\uae4c\uc9c0 \uc5f0\ud3c9\uade0 11.06%\ub85c \uc131\uc7a5\ud560 \uac83\uc73c\ub85c \uc608\uc0c1\ub429\ub2c8\ub2e4.<br \/>\n*   \ucd5c\uc885 \uc0ac\uc6a9\uc790: \ubcd1\uc6d0\uc774 2025\ub144 58.88%\uc758 \uc810\uc720\uc728\uc744 \uae30\ub85d\ud588\uc73c\uba70, SC \uc0dd\ubb3c\ud559\uc801 \uc81c\uc81c\uac00 \uc790\uac00 \ud22c\uc5ec\ub97c \uac00\ub2a5\ud558\uac8c \ud568\uc5d0 \ub530\ub77c \uc7ac\ud0dd \uce58\ub8cc \ud658\uacbd\uc774 \uc5f0\ud3c9\uade0 10.54%\ub85c \uc99d\uac00\ud558\uace0 \uc788\uc2b5\ub2c8\ub2e4.<br \/>\n*   \uc9c0\uc5ed: \ubd81\ubbf8\uac00 2025\ub144 \ub9e4\ucd9c\uc758 44.01%\ub97c \ucc28\uc9c0\ud588\uc73c\uba70, \uc544\uc2dc\uc544 \ud0dc\ud3c9\uc591 \uc9c0\uc5ed\uc740 2031\ub144\uae4c\uc9c0 \uc5f0\ud3c9\uade0 9.46%\ub85c \uac00\uc7a5 \ube60\ub974\uac8c \uc131\uc7a5\ud558\ub294 \uc9c0\uc5ed\uc785\ub2c8\ub2e4.<\/p>\n<p>\uae00\ub85c\ubc8c \uc911\uc99d\uadfc\ubb34\ub825\uc99d \uce58\ub8cc\uc81c \uc2dc\uc7a5 \ub3d9\ud5a5 \ubc0f \ud1b5\ucc30\ub825:<\/p>\n<p>\uc131\uc7a5 \ub3d9\ub825:<\/p>\n<p>*   \uc911\uc99d\uadfc\ubb34\ub825\uc99d(MG) \ubc1c\ubcd1\ub960 \uc99d\uac00 \ubc0f \uc870\uae30 \uc9c4\ub2e8: 2024\ub144 \ubbf8\uad6d \ub0b4 MG \ubc1c\ubcd1\ub960\uc740 \ubc31\ub9cc \uba85\ub2f9 68.5\uba85\uc73c\ub85c \uc99d\uac00\ud588\uc73c\uba70, \uc774\ub294 \uc9c8\ubcd1 \uc778\uc2dd \uc99d\uac00\uc640 \uc2e0\uacbd\uadfc\uc721 \uac80\uc0ac\uc5d0 \ub300\ud55c \ubcf4\ud5d8 \uc801\uc6a9 \ud655\ub300\uc5d0 \uae30\uc778\ud569\ub2c8\ub2e4. AI \uae30\ubc18 \uc548\uad6c \uc6b4\ub3d9 \ubd84\uc11d \ub3c4\uad6c\ub294 \uc9c4\ub2e8 \uc9c0\uc5f0\uc744 2.3\ub144\uc5d0\uc11c 12\uac1c\uc6d4 \ubbf8\ub9cc\uc73c\ub85c \ub2e8\ucd95\uc2dc\ud0a4\ub294 \ub370 \uae30\uc5ec\ud558\uba70, \uc870\uae30 \uc9c4\ub2e8\uc740 \uba74\uc5ed \uc870\uc808 \uce58\ub8cc\uc758 \uc870\uae30 \uc2dc\uc791\uc744 \uac00\ub2a5\ud558\uac8c \ud558\uc5ec \ud658\uc790 \ud480\uc744 \ud655\ub300\ud558\uace0 \uc788\uc2b5\ub2c8\ub2e4.<br \/>\n*   \ubcf4\uccb4 \ubc0f FcRn \ud45c\uc801 \uc0dd\ubb3c\ud559\uc801 \uc81c\uc81c\uc758 \uc2b9\uc778 \uac00\uc18d\ud654: 2023\ub144\ubd80\ud130 2025\ub144 \uc0ac\uc774\uc5d0 \ub85c\uc790\ub180\ub9ac\uc2dc\uc8fc\ub9d9(rozanolixizumab), \uc9c8\ub8e8\ucf54\ud50c\ub780(zilucoplan), \ub2c8\ud3ec\uce7c\ub9ac\ub9d9(nipocalimab), SC \uc5d0\ud504\uac00\ud2f0\uc9c0\ubaa8\ub4dc(efgartigimod) \ub4f1 4\uac00\uc9c0 \ud601\uc2e0 \uc2e0\uc57d\uc774 \uc6b0\uc120 \uc2ec\uc0ac \uacbd\ub85c\ub97c \ud1b5\ud574 6~8\uac1c\uc6d4 \ub9cc\uc5d0 \uaddc\uc81c \uc2b9\uc778\uc744 \uc644\ub8cc\ud588\uc2b5\ub2c8\ub2e4. \uc774\ub7ec\ud55c \ub2e8\ucd95\ub41c \uc2b9\uc778 \uae30\uac04\uc740 \ubca4\ucc98 \ud22c\uc790\uc640 \ub300\ud615 \uc81c\uc57d\uc0ac \uac70\ub798\ub97c \ucd09\uc9c4\ud558\uba70, \ub3d9\uc2dc \ub2e4\ubc1c\uc801\uc778 \uae00\ub85c\ubc8c \ucd9c\uc2dc\ub294 \ub3c5\uc810 \uae30\uac04 \ub3d9\uc548 \uc804 \uc138\uacc4\uc801\uc778 \uc218\uc775 \ud655\ubcf4\ub97c \uac00\uc18d\ud654\ud569\ub2c8\ub2e4.<br \/>\n*   \ud76c\uadc0 \uc9c8\ud658 \uc778\uc13c\ud2f0\ube0c \ubc0f \ud504\ub9ac\ubbf8\uc5c4 \uac00\uaca9 \ucc45\uc815\uc758 \ud65c\uc6a9: \ud76c\uadc0\uc758\uc57d\ud488 \uc9c0\uc815\uc740 7\ub144\uac04\uc758 \ub3c5\uc810\uad8c, 25%\uc758 R&#038;D \uc138\uae08 \uacf5\uc81c, FDA \uc0ac\uc6a9\uc790 \uc218\uc218\ub8cc \uba74\uc81c \ub4f1 \uc0c1\ub2f9\ud55c \uaddc\uc81c \ube44\uc6a9 \uc808\uac10 \ud61c\ud0dd\uc744 \uc81c\uacf5\ud569\ub2c8\ub2e4. \ud658\uc790\ub2f9 \uc5f0\uac04 80\ub9cc \ub2ec\ub7ec\ub97c \ucd08\uacfc\ud558\ub294 \ub192\uc740 \uc57d\uac00\uc5d0\ub3c4 \ubd88\uad6c\ud558\uace0, \uc131\uacfc \uae30\ubc18 \uacc4\uc57d\uc740 \uc9c0\ubd88\uc790\uc758 \ubc18\ubc1c\uc744 \uc644\ud654\ud558\uba74\uc11c \uac15\ub825\ud55c \uc21c\uc218\uc775 \ud750\ub984\uc744 \uc720\uc9c0\ud569\ub2c8\ub2e4.<br \/>\n*   \uc790\uac00 \ud22c\uc5ec SC \uc0dd\ubb3c\ud559\uc801 \uc81c\uc81c\uc758 \uc21c\uc751\ub3c4 \ud5a5\uc0c1: \uc790\uac00 \uc8fc\uc0ac\ud615 \ub85c\uc790\ub180\ub9ac\uc2dc\uc8fc\ub9d9\uc5d0 \ub300\ud55c EMA \uc2b9\uc778 \ubc0f \ubc14\uc774\ubc14\ud2b8 \ud558\uc774\ud2b8\ub8f0\ub85c(Vyvgart Hytrulo) \uc0ac\uc804 \ucda9\uc804\ud615 \uc8fc\uc0ac\uae30\uc5d0 \ub300\ud55c FDA \uc2b9\uc778\uc740 \ud658\uc790 \uc790\uac00 \ud22c\uc5ec\uc758 \uc548\uc804\uc131\uacfc \ud6a8\ub2a5\uc744 \uc785\uc99d\ud588\uc2b5\ub2c8\ub2e4. SC \ud22c\uc5ec\ub294 \uc9d1\uc5d0\uc11c 5\ubd84 \ub9cc\uc5d0 \uc644\ub8cc\ud560 \uc218 \uc788\uc5b4, \uc218 \uc2dc\uac04 \uac78\ub9ac\ub294 \uc8fc\uc785 \ubc29\ubb38\uc5d0 \ube44\ud574 \ud3b8\uc758\uc131\uc774 \ub192\uc544 \uc21c\uc751\ub3c4\ub97c 89%\uae4c\uc9c0 \ub04c\uc5b4\uc62c\ub9bd\ub2c8\ub2e4. \uc774\ub294 \uce58\ub8cc \uc811\uadfc\uc131\uc744 \ub192\uc5ec \uc2dc\uc7a5 \uaddc\ubaa8\ub97c \ud655\ub300\ud569\ub2c8\ub2e4.<\/p>\n<p>\uc2dc\uc7a5 \uc81c\uc57d \uc694\uc778:<\/p>\n<p>*   \uc7a5\uae30 \uc0dd\ubb3c\ud559\uc801 \uc694\ubc95\uc758 \ub192\uc740 \ube44\uc6a9: FcRn \uc5b5\uc81c\uc81c\uc758 \uc5f0\uac04 \uc9c0\ucd9c\uc740 \uc57d 83\ub9cc 3\ucc9c \ub2ec\ub7ec\uc5d0 \ub2ec\ud558\uba70, \ube44\uc6a9-\ud6a8\uc6a9\uc131 \uc5f0\uad6c\uc5d0 \ub530\ub974\uba74 \ubbf8\uad6d\uacfc \uc720\ub7fd\uc5d0\uc11c \uc9c0\ubd88 \uc758\uc0ac \uc784\uacc4\uac12\uc744 \ucda9\uc871\ud558\ub824\uba74 \uc57d\uac00\uac00 \ucd5c\ub300 88%\uae4c\uc9c0 \uc778\ud558\ub418\uc5b4\uc57c \ud569\ub2c8\ub2e4. \ub192\uc740 \ube44\uc6a9\uc740 \uc0ac\uc804 \uc2b9\uc778 \uc9c0\uc5f0\uc744 \uc720\ubc1c\ud558\uace0, \uc2e0\ud765 \uc2dc\uc7a5 \ud658\uc790\ub4e4\uc740 \ub192\uc740 \ubcf8\uc778 \ubd80\ub2f4\uae08\uc73c\ub85c \uc778\ud574 \uc2a4\ud14c\ub85c\uc774\ub4dc\ub098 \ud608\uc7a5 \uad50\ud658\uc220\uc5d0 \uc758\uc874\ud558\uac8c \ub429\ub2c8\ub2e4.<br \/>\n*   \uc2e0\ud765 \uacbd\uc81c\uad6d\uc758 \ub0ae\uc740 \uc9c8\ubcd1 \uc778\uc2dd: \uc544\uc2dc\uc544 \ud0dc\ud3c9\uc591 \ubc0f \ub77c\ud2f4 \uc544\uba54\ub9ac\uce74 \uc9c0\uc5ed\uc758 \ub9ce\uc740 \uad6d\uac00\uc5d0\uc11c \uc911\uc99d\uadfc\ubb34\ub825\uc99d\uc5d0 \ub300\ud55c 1\ucc28 \uc9c4\ub8cc \uc758\uc0ac\uc758 \uc778\uc9c0\ub3c4\ub294 30% \ubbf8\ub9cc\uc774\uba70, \ucd08\uae30 \uc624\uc9c4\uc728\uc740 60%\ub97c \ucd08\uacfc\ud569\ub2c8\ub2e4. \uc774\ub294 \uc9c8\ubcd1 \uc870\uc808 \uce58\ub8cc\uc5d0 \ub300\ud55c \uc811\uadfc\uc744 \uc9c0\uc5f0\uc2dc\ucf1c \uc2dc\uc7a5 \uce68\ud22c\ub97c \uc81c\ud55c\ud569\ub2c8\ub2e4.<br \/>\n*   \uc194\ub9ac\ub9ac\uc2a4(Soliris) \ud2b9\ud5c8 \ub9cc\ub8cc \ubc0f \ubc14\uc774\uc624\uc2dc\ubc00\ub7ec \uc9c4\uc785 \ud6c4 \uac00\uaca9 \ud558\ub77d \uc704\ud5d8: \uc194\ub9ac\ub9ac\uc2a4 \ud2b9\ud5c8 \ub9cc\ub8cc \ubc0f \ubc14\uc774\uc624\uc2dc\ubc00\ub7ec\uc758 \uc2dc\uc7a5 \uc9c4\uc785\uc740 \ud2b9\ud788 \ubd81\ubbf8\uc640 \uc720\ub7fd \uc2dc\uc7a5\uc5d0\uc11c \uac00\uaca9 \ud558\ub77d \uc555\ub825\uc744 \uac00\uc911\uc2dc\ud0ac \uc218 \uc788\uc2b5\ub2c8\ub2e4.<\/p>\n<p>\uc138\uadf8\uba3c\ud2b8 \ubd84\uc11d:<\/p>\n<p>*   \uce58\ub8cc\ubc95\ubcc4: \uc720\uc804\uc790 \ubc0f \uc138\ud3ec \uce58\ub8cc\ubc95\uc740 \uc5f0\ud3c9\uade0 9.41%\ub85c \uac00\uc7a5 \ube60\ub974\uac8c \uc131\uc7a5\ud558\ub294 \uce58\ub8cc\ubc95\uc774\uc9c0\ub9cc, \uc57d\ubb3c \uce58\ub8cc\uac00 2025\ub144 \ub9e4\ucd9c\uc758 68.74%\ub97c \ucc28\uc9c0\ud558\uba70 \uc5ec\uc804\ud788 \ud070 \ube44\uc911\uc744 \ucc28\uc9c0\ud569\ub2c8\ub2e4. CAR-T \ubc0f CAART \uae30\uc220\uacfc \uac19\uc740 \ud601\uc2e0\uc801\uc778 \uc811\uadfc\ubc95\uc740 \uc644\uce58 \uac00\ub2a5\uc131\uc5d0 \ub300\ud55c \uae30\ub300\ub97c \ub192\uc774\uace0 \uc788\uc2b5\ub2c8\ub2e4. \uae30\uc874 \uc57d\ubb3c(\uc2a4\ud14c\ub85c\uc774\ub4dc, \ucf5c\ub9b0\uc5d0\uc2a4\ud14c\ub77c\uc81c \uc5b5\uc81c\uc81c, IVIg)\uc740 \uacbd\uc99d \ub610\ub294 \uae09\uc131 \uc9c4\ud589\uc131 \uc5d0\ud53c\uc18c\ub4dc \uad00\ub9ac\uc5d0 \uc5ec\uc804\ud788 \uc911\uc694\ud558\uba70, \uc0dd\ubb3c\ud559\uc801 \uc81c\uc81c\uc640 \ud45c\uc801 \uc720\uc804\uc790 \ud3b8\uc9d1\uc744 \uacb0\ud569\ud55c \ud558\uc774\ube0c\ub9ac\ub4dc \uce58\ub8cc \ubaa8\ub378\uc774 \ub4f1\uc7a5\ud560 \uc218 \uc788\uc2b5\ub2c8\ub2e4.<br \/>\n*   \ud22c\uc5ec \uacbd\ub85c\ubcc4: \ud53c\ud558(SC) \ud22c\uc5ec\ub294 \uc5f0\ud3c9\uade0 9.85%\ub85c \uc131\uc7a5\ud558\uba70 2025\ub144 \ub9e4\ucd9c\uc758 62.90%\ub97c \ucc28\uc9c0\ud55c \uc815\ub9e5 \uc8fc\uc0ac(IV)\uc758 \uc9c0\ubc30\ub825\uc744 \uc57d\ud654\uc2dc\ud0ac \uac83\uc73c\ub85c \uc608\uc0c1\ub429\ub2c8\ub2e4. \uc790\uac00 \uc8fc\uc0ac\ud615 \ub85c\uc790\ub180\ub9ac\uc2dc\uc8fc\ub9d9 \ubc0f \ubc14\uc774\ubc14\ud2b8 \ud558\uc774\ud2b8\ub8f0\ub85c \uc0ac\uc804 \ucda9\uc804\ud615 \uc8fc\uc0ac\uae30\uc758 \uc2b9\uc778\uc740 \ud658\uc790 \ud3b8\uc758\uc131\uc744 \ub192\uc5ec \uc21c\uc751\ub3c4\ub97c \ud5a5\uc0c1\uc2dc\ud0a4\uace0, \ub18d\ucd0c \uc9c0\uc5ed \ubc0f \uc774\ub3d9\uc774 \uc81c\ud55c\uc801\uc778 \ud658\uc790\ub4e4\uc5d0\uac8c \uce58\ub8cc \uc811\uadfc\uc131\uc744 \ud655\ub300\ud569\ub2c8\ub2e4.<br \/>\n*   \uc57d\ubb3c \ubd84\ub958\ubcc4: \ub2e8\uc77c\ud074\ub860\ud56d\uccb4\ub294 2031\ub144\uae4c\uc9c0 \uc5f0\ud3c9\uade0 11.06%\ub85c \uac00\uc7a5 \ub192\uc740 \uc131\uc7a5\ub960\uc744 \ubcf4\uc774\uba70, \ucf5c\ub9b0\uc5d0\uc2a4\ud14c\ub77c\uc81c \uc5b5\uc81c\uc81c\uac00 2025\ub144 \ub9e4\ucd9c\uc758 45.98%\ub97c \ucc28\uc9c0\ud588\uc2b5\ub2c8\ub2e4. \uc5d0\ud504\uac00\ud2f0\uc9c0\ubaa8\ub4dc, \ub85c\uc790\ub180\ub9ac\uc2dc\uc8fc\ub9d9, \ub2c8\ud3ec\uce7c\ub9ac\ub9d9\uacfc \uac19\uc740 FcRn \uae38\ud56d\uc81c\ub294 IgG \uac10\uc18c\uc5d0 \ud6a8\uacfc\uc801\uc774\uba70, \ubcf4\uccb4 \uc5b5\uc81c\uc81c\ub294 \ubcf4\uccb4 \ub9e4\uac1c \ubcd1\ub9ac \ud658\uc790\uc5d0\uac8c \uc911\uc694\ud569\ub2c8\ub2e4. \ud30c\uc774\ud504\ub77c\uc778 \ub2e4\uac01\ud654\ub294 C2 \uc5b5\uc81c\uc81c \ubc0f MuSK \uc791\uc6a9\uc81c\ub97c \ud3ec\ud568\ud558\uba70, \ub370\uc774\ud130 \uae30\ubc18\uc758 \uac1c\uc778 \ub9de\ucda4\ud615 \uc57d\ubb3c \uc120\ud0dd\uc774 \ud655\uc0b0\ub420 \uac83\uc785\ub2c8\ub2e4.<br \/>\n*   \ucd5c\uc885 \uc0ac\uc6a9\uc790\ubcc4: \uc7ac\ud0dd \uce58\ub8cc \ud658\uacbd\uc740 \uc5f0\ud3c9\uade0 10.54%\ub85c \uac00\uc7a5 \ube60\ub974\uac8c \uc131\uc7a5\ud558\uba70, 2025\ub144 58.88%\uc758 \uc810\uc720\uc728\uc744 \ucc28\uc9c0\ud55c \ubcd1\uc6d0\uc758 \uc5ed\ud560\uc744 \ubcc0\ud654\uc2dc\ud0a4\uace0 \uc788\uc2b5\ub2c8\ub2e4. \ucf54\ub85c\ub09819 \ud32c\ub370\ubbf9\uc740 \uc790\uac00 \uc8fc\uc0ac \ubc0f \uc6d0\uaca9 \ubaa8\ub2c8\ud130\ub9c1\uc744 \ubcf4\ud3b8\ud654\ud588\uc73c\uba70, AI \uae30\ubc18 \ud50c\ub7ab\ud3fc\uc740 \uc6d0\uaca9 \uc2e0\uacbd\uadfc\uc721 \uac80\uc0ac\ub97c \uc790\ub3d9\ud654\ud558\uc5ec \uc7ac\ud0dd \uce58\ub8cc\ub97c \uc9c0\uc6d0\ud569\ub2c8\ub2e4. \ubcd1\uc6d0\uc740 \ucd08\uae30 \ud3c9\uac00, \uc8fc\uc785 \uc801\uc815, \uc704\uae30 \uad00\ub9ac \ub4f1\uc5d0\uc11c \uc5ec\uc804\ud788 \uc911\uc694\ud55c \uc5ed\ud560\uc744 \ud558\uc9c0\ub9cc, \uc720\uc9c0 \uc6a9\ub7c9 \ud22c\uc5ec\ub294 \uc810\ucc28 \ud658\uc790\uc758 \uc9d1\uc73c\ub85c \uc804\ud658\ub420 \uac83\uc785\ub2c8\ub2e4.<\/p>\n<p>\uc9c0\uc5ed\ubcc4 \ubd84\uc11d:<\/p>\n<p>*   \ubd81\ubbf8: 2025\ub144 \ub9e4\ucd9c\uc758 44.01%\ub97c \ucc28\uc9c0\ud558\uba70, \uad11\ubc94\uc704\ud55c \ubcf4\ud5d8 \uc801\uc6a9\uacfc FDA \ud601\uc2e0 \uce58\ub8cc\uc81c \uc9c0\uc815\uc5d0 \ub530\ub978 \uc0dd\ubb3c\ud559\uc801 \uc81c\uc81c\uc758 \ube60\ub978 \ucc44\ud0dd\uc774 \uc131\uc7a5\uc744 \uacac\uc778\ud569\ub2c8\ub2e4. AI \uae30\ubc18 \uc548\uad6c \uc6b4\ub3d9 \uac80\uc0ac \ubc0f \uc6d0\uaca9 \uc2e0\uacbd\ud559\uc740 \uc804\ubb38\uac00 \ubcd1\ubaa9 \ud604\uc0c1\uc744 \uc904\uc5ec \uc870\uae30 \uce58\ub8cc \uc2dc\uc791\uc744 \ucd09\uc9c4\ud569\ub2c8\ub2e4. \uc874\uc2a8\uc564\ub4dc\uc874\uc2a8\uc758 \ub2c8\ud3ec\uce7c\ub9ac\ub9d9 \ucd9c\uc2dc\ub294 \uacbd\uc7c1 \uac15\ub3c4\ub97c \ub192\uc5ec \ud658\uc790 \uc811\uadfc\uc131\uc744 \ud655\ub300\ud560 \uc218 \uc788\uc2b5\ub2c8\ub2e4.<br \/>\n*   \uc720\ub7fd: 2024\ub144 1\uc6d4 \ub85c\uc790\ub180\ub9ac\uc2dc\uc8fc\ub9d9 \uc2b9\uc778 \ubc0f 2025\ub144 2\uc6d4 SC \uc790\uac00 \ud22c\uc5ec \uc2b9\uc778 \ub4f1 \uc77c\uad00\ub41c \uaddc\uc81c \ud658\uacbd\uc744 \uac16\ucd94\uace0 \uc788\uc2b5\ub2c8\ub2e4. \uac74\uac15 \uae30\uc220 \ud3c9\uac00(HTA)\ub294 20~30%\uc758 \uc57d\uac00 \ud560\uc778\uc744 \uc694\uad6c\ud558\uc9c0\ub9cc, \uc2e4\uc81c \ub370\uc774\ud130\uc5d0\uc11c \uc2a4\ud14c\ub85c\uc774\ub4dc \uc0ac\uc6a9 \uac10\uc18c \ubc0f \uc704\uae30 \ubc1c\uc0dd\ub960 \uac10\uc18c\ub97c \ubcf4\uc5ec\uc8fc\ub294 \ud76c\uadc0\uc758\uc57d\ud488\uc758 \uac00\uce58\ub97c \uc778\uc815\ud569\ub2c8\ub2e4. \uc720\ub7fd \ud658\uc790\uc758 83%\uac00 SC \ud22c\uc5ec\ub97c \uc120\ud638\ud558\uc5ec, \uc9c0\ubd88\uc790\ub4e4\uc740 \uc8fc\uc785 \uc608\uc0b0\uc744 \uc57d\ubb3c \uad6c\ub9e4\ub85c \uc7ac\ud560\ub2f9\ud560 \uc218 \uc788\uc2b5\ub2c8\ub2e4.<br \/>\n*   \uc544\uc2dc\uc544 \ud0dc\ud3c9\uc591: 2031\ub144\uae4c\uc9c0 \uc5f0\ud3c9\uade0 9.46%\ub85c \uac00\uc7a5 \ube60\ub974\uac8c \uc131\uc7a5\ud558\ub294 \uc9c0\uc5ed\uc785\ub2c8\ub2e4. \uc77c\ubcf8 \uc758\uc57d\ud488\uc758\ub8cc\uae30\uae30\uc885\ud569\uae30\uad6c(PMDA) \ubc0f \uc911\uad6d \uad6d\uac00\uc57d\ud488\uac10\ub3c5\uad00\ub9ac\uad6d(NMPA)\uc758 \uc2b9\uc778 \uc808\ucc28\uac00 \ubbf8\uad6d\ubcf4\ub2e4 6\uac1c\uc6d4 \uc774\ub0b4\ub85c \ub2e8\ucd95\ub418\uba74\uc11c \uc131\uc7a5\uc774 \uac00\uc18d\ud654\ub418\uace0 \uc788\uc2b5\ub2c8\ub2e4. \uc77c\ubcf8\uc740 \uc804\uc2e0 \uc911\uc99d\uadfc\ubb34\ub825\uc99d \ubc0f \uba74\uc5ed\uc131 \ud608\uc18c\ud310 \uac10\uc18c\uc99d \uce58\ub8cc\uc81c\ub85c \uc5d0\ud504\uac00\ud2f0\uc9c0\ubaa8\ub4dc\ub97c \uc2b9\uc778\ud588\uc73c\uba70, \uc911\uad6d\uc740 gMG \ubc0f CIDP \uce58\ub8cc\uc81c\ub85c IV \ubc0f SC \uc81c\ud615\uc744 \ubaa8\ub450 \uc2b9\uc778\ud588\uc2b5\ub2c8\ub2e4. \uadf8\ub7ec\ub098 \uc911\uad6d\uc758 \ub192\uc740 \ubcf8\uc778 \ubd80\ub2f4\uae08\uc740 \uace0\uac00 \uc0dd\ubb3c\ud559\uc801 \uc81c\uc81c\uc758 \ud65c\uc6a9\uc744 \uc81c\ud55c\ud558\uba70, \uc758\ub8cc \uc778\ud504\ub77c \ud22c\uc790 \ubc0f \ud604\uc9c0 \uc81c\uc870 \uc774\ub2c8\uc154\ud2f0\ube0c\uac00 \ud5a5\ud6c4 10\ub144\uac04 \uc9c0\uc5ed \uc2dc\uc7a5 \uae30\uc5ec\ub3c4\ub97c \ub192\uc77c \uac83\uc73c\ub85c \uc608\uc0c1\ub429\ub2c8\ub2e4.<\/p>\n<p>\uacbd\uc7c1 \ud658\uacbd:<\/p>\n<p>\uc911\uc99d\uadfc\ubb34\ub825\uc99d \uce58\ub8cc\uc81c \uc2dc\uc7a5\uc740 \uc911\uac04 \uc815\ub3c4\uc758 \ud1b5\ud569\ub3c4\ub97c \ubcf4\uc785\ub2c8\ub2e4. \uc544\ub974\uc820\uc5d1\uc2a4\ub294 2024\ub144 3\ubd84\uae30 \ubc14\uc774\ubc14\ud2b8(Vyvgart) \ub9e4\ucd9c 5\uc5b5 7,300\ub9cc \ub2ec\ub7ec\ub97c \uae30\ub85d\ud558\uba70 \uc120\ub450\ub97c \uc720\uc9c0\ud558\uace0 \uc788\uc73c\uba70, 2030\ub144\uae4c\uc9c0 \uc804 \uc138\uacc4 5\ub9cc \uba85\uc758 \ud658\uc790\ub97c \ubaa9\ud45c\ub85c \ud569\ub2c8\ub2e4. \uc874\uc2a8\uc564\ub4dc\uc874\uc2a8\uc758 2025\ub144 5\uc6d4 \ub2c8\ud3ec\uce7c\ub9ac\ub9d9 \uc2b9\uc778\uc740 \uc704\uc57d \ub300\ube44 4\ubc30 \ub192\uc740 \uc9c0\uc18d\uc801\uc778 \uc99d\uc0c1 \uac1c\uc120 \ud6a8\uacfc\ub97c \ubcf4\uc5ec\uc8fc\uba70, \uae00\ub85c\ubc8c \uba74\uc5ed\ud559 \ud504\ub79c\ucc28\uc774\uc988\ub97c \ud1b5\ud574 \uc989\uac01\uc801\uc778 \uaddc\ubaa8\ub97c \ud655\ubcf4\ud588\uc2b5\ub2c8\ub2e4. UCB\uc758 \ub85c\uc790\ub180\ub9ac\uc2dc\uc8fc\ub9d9\uc740 \uc790\uac00 \uc8fc\uc0ac \ubc0f \uc774\uc911 AChR\/MuSK \uc801\uc751\uc99d\uc73c\ub85c \ucc28\ubcc4\ud654\ub429\ub2c8\ub2e4. \uc544\uc2a4\ud2b8\ub77c\uc81c\ub124\uce74(AstraZeneca)\uc758 \ubcf4\uccb4 \uc5b5\uc81c\uc81c \ub77c\uc778\uc740 FcRn \uce68\ud22c\uc5d0 \ucde8\uc57d\ud558\uc9c0\ub9cc, \ubcf4\uccb4 \uc591\uc131 \ud558\uc704 \uadf8\ub8f9\uc5d0\uc11c \ucda9\uc131\ub3c4\ub97c \uc720\uc9c0\ud569\ub2c8\ub2e4. \uc774\ubba4\ub178\ubc18\ud2b8(Immunovant)\uc758 \ubc14\ud1a0\ud074\ub9ac\ub9d9(batoclimab)\uc740 3\uc0c1\uc5d0\uc11c 5.6\uc810\uc758 MG-ADL \uac1c\uc120\uc744 \ubcf4\uc5ec IgG \uac10\uc18c \uae4a\uc774\uc5d0\uc11c \uacbd\uc7c1\uc744 \uc2ec\ud654\uc2dc\ud0ac \uc218 \uc788\uc2b5\ub2c8\ub2e4. \uc544\ub974\uc820\uc5d1\uc2a4\uc640 \ud560\ub85c\uc790\uc784(Halozyme)\uc758 Enhanze \ud30c\ud2b8\ub108\uc2ed\uacfc \uac19\uc740 \uae30\uc220 \uc81c\ud734\ub294 \uc0c8\ub85c\uc6b4 SC \ud6c4\ubcf4 \ubb3c\uc9c8\uc744 \uac1c\ubc1c\ud558\uc5ec \uc2dc\uc7a5 \uacbd\uc7c1\ub825\uc744 \uac15\ud654\ud558\uace0 \uc788\uc2b5\ub2c8\ub2e4. CAART \uac1c\ubc1c\uc0ac\uc640 \uac19\uc740 \uc720\uc804\uc790 \uce58\ub8cc\uc81c \uc2e0\uaddc \uc9c4\uc785 \uae30\uc5c5\ub4e4\uc740 \uc9c0\uc18d\uc801\uc778 \uad00\ud574 \uc790\uc0b0\uc744 \ud655\ubcf4\ud558\ub824\ub294 \ub300\ud615 \uc81c\uc57d\uc0ac\uc758 \uc778\uc218 \ub300\uc0c1\uc774 \ub420 \uac00\ub2a5\uc131\uc774 \ub192\uc2b5\ub2c8\ub2e4.<\/p>\n<p>\uac00\uaca9 \ucc45\uc815\uc740 \uc720\ub3d9\uc801\uc785\ub2c8\ub2e4. \ube44\uc6a9-\ud6a8\uc6a9\uc131 \uc5f0\uad6c\ub294 \ub300\ud3ed\uc801\uc778 \ud560\uc778\uc744 \uc694\uad6c\ud558\uc9c0\ub9cc, \uc131\uacfc \uae30\ubc18 \uacc4\uc57d \ubc0f \ubc88\ub4e4\ud615 \ub9cc\uc131 \uce58\ub8cc \ubaa8\ub378\uc740 \uc704\uae30 \uac10\uc18c \ubc0f \uc2a4\ud14c\ub85c\uc774\ub4dc \uc808\uc57d \ud6a8\uacfc\ub97c \uc785\uc99d\ud560 \uacbd\uc6b0 \uc81c\uc870\uc5c5\uccb4\uc5d0 \uac00\uaca9 \ucc45\uc815\uc758 \uc720\uc5f0\uc131\uc744 \ubd80\uc5ec\ud569\ub2c8\ub2e4. \ub354 \ub9ce\uc740 \uc57d\ubb3c\uc774 \uc2dc\uc7a5\uc5d0 \uc9c4\uc785\ud568\uc5d0 \ub530\ub77c, \uad6d\uac00 \uc2dc\uc2a4\ud15c\uc740 \uacbd\uc7c1 \uc785\ucc30\uc744 \ud1b5\ud574 \uc21c\uac00\uaca9\uc744 \ub0ae\ucd9c \uc218 \uc788\uc9c0\ub9cc, \ub192\uc740 \uba74\uc5ed\ud559 \ub9c8\uc9c4\uacfc \ubd80\uc871\ud55c \uc81c\uc870 \uc5ed\ub7c9\uc740 2030\ub144 \uc774\uc804\uae4c\uc9c0\ub294 \uc624\ub9ac\uc9c0\ub110 \uc758\uc57d\ud488\uc774 \ubc14\uc774\uc624\uc2dc\ubc00\ub7ec\ubcf4\ub2e4 \uc720\ub9ac\ud55c \uc704\uce58\ub97c \ucc28\uc9c0\ud558\uac8c \ud560 \uac83\uc785\ub2c8\ub2e4.<\/p>\n<p>\uc8fc\uc694 \uc2dc\uc7a5 \ucc38\uc5ec\uc790:<\/p>\n<p>*   \uc544\ub974\uc820\uc5d1\uc2a4(argenx SE)<br \/>\n*   UCB \ud30c\ub9c8(UCB Pharma)<br \/>\n*   \uc874\uc2a8\uc564\ub4dc\uc874\uc2a8(Johnson &#038; Johnson)<br \/>\n*   \ub178\ubc14\ud2f0\uc2a4(Novartis AG)<br \/>\n*   \uc544\uc2a4\ud2b8\ub77c\uc81c\ub124\uce74(AstraZeneca)<\/p>\n<p>\ucd5c\uadfc \uc0b0\uc5c5 \ub3d9\ud5a5:<\/p>\n<p>*   2025\ub144 4\uc6d4: \uc874\uc2a8\uc564\ub4dc\uc874\uc2a8\uc740 \uc804\uc2e0 \uc911\uc99d\uadfc\ubb34\ub825\uc99d \uce58\ub8cc\uc81c \ub2c8\ud3ec\uce7c\ub9ac\ub9d9(Nipocalimab, Imaavy)\uc5d0 \ub300\ud574 FDA \uc2b9\uc778\uc744 \ud68d\ub4dd\ud588\uc73c\uba70, \uc704\uc57d \ub300\ube44 4\ubc30 \ub192\uc740 \uc9c0\uc18d\uc801\uc778 \uc99d\uc0c1 \uc870\uc808 \ud6a8\uacfc\ub97c \ubcf4\uc600\uc2b5\ub2c8\ub2e4.<br \/>\n*   2025\ub144 4\uc6d4: \uc544\ub974\uc820\uc5d1\uc2a4\ub294 \ud658\uc790 \uc790\uac00 \ud22c\uc5ec\uac00 \uac00\ub2a5\ud55c \ubc14\uc774\ubc14\ud2b8 \ud558\uc774\ud2b8\ub8f0\ub85c(Vyvgart Hytrulo) \uc0ac\uc804 \ucda9\uc804\ud615 \uc8fc\uc0ac\uae30\uc5d0 \ub300\ud574 FDA \uc2b9\uc778\uc744 \ubc1b\uc558\uc2b5\ub2c8\ub2e4.<br \/>\n*   2025\ub144 4\uc6d4: \ub808\uba54\uc820(RemeGen)\uc740 \ud154\ub9ac\ud0c0\uc2dc\uc149\ud2b8(Telitacicept)\uc758 3\uc0c1 \uc784\uc0c1\uc5d0\uc11c 98.1%\uc758 MG-ADL \ubc18\uc751\ub960\uc744 \ubc1c\ud45c\ud588\uc73c\uba70, 2025\ub144 2\ubd84\uae30 \uc911\uad6d \uc2b9\uc778\uc774 \uc608\uc0c1\ub429\ub2c8\ub2e4.<br \/>\n*   2025\ub144 3\uc6d4: \uc774\ubba4\ub178\ubc18\ud2b8(Immunovant)\ub294 3\uc0c1 \ubc14\ud1a0\ud074\ub9ac\ub9d9(Batoclimab) \ub370\uc774\ud130\ub97c \ubc1c\ud45c\ud558\uba70 \uc8fc 680mg \ud22c\uc5ec \uc2dc 5.6\uc810\uc758 MG-ADL \uac1c\uc120\uc744 \ub2ec\uc131\ud588\ub2e4\uace0 \ubc1d\ud614\uc2b5\ub2c8\ub2e4.<\/p>\n<p>\ubcf8 \ubcf4\uace0\uc11c\ub294 \uc2e0\uacbd\uadfc\uc721 \uc790\uac00\uba74\uc5ed \uc9c8\ud658\uc778 \uc911\uc99d\uadfc\ubb34\ub825\uc99d(Myasthenia Gravis, MG) \uce58\ub8cc\uc81c \uc2dc\uc7a5\uc5d0 \ub300\ud55c \ud3ec\uad04\uc801\uc778 \ubd84\uc11d\uc744 \uc81c\uacf5\ud569\ub2c8\ub2e4. \uc911\uc99d\uadfc\ubb34\ub825\uc99d\uc740 \uc2e0\uacbd \uc138\ud3ec\uc640 \uadfc\uc721 \uac04\uc758 \ud1b5\uc2e0 \uc7a5\uc560\ub85c \uc778\ud574 \uace8\uaca9\uadfc \uc57d\ud654\ub97c \uc720\ubc1c\ud558\ub294 \ub9cc\uc131 \uc9c8\ud658\uc73c\ub85c, \ud604\uc7ac \uc644\uce58\ubc95\uc740 \uc5c6\uc73c\ub098 \uc57d\ubb3c \uce58\ub8cc\ub97c \ud1b5\ud574 \uc99d\uc0c1 \uad00\ub9ac\uac00 \uac00\ub2a5\ud569\ub2c8\ub2e4. \ubcf8 \uc5f0\uad6c\ub294 \uc2dc\uc7a5 \uc815\uc758, \ubc94\uc704, \uc5f0\uad6c \ubc29\ubc95\ub860\uc744 \ud3ec\ud568\ud558\uc5ec \uc2dc\uc7a5 \ub3d9\ud5a5, \uc131\uc7a5 \uc608\uce21, \uacbd\uc7c1 \ud658\uacbd \ubc0f \ubbf8\ub798 \uae30\ud68c\ub97c \uc2ec\uce35\uc801\uc73c\ub85c \ub2e4\ub8f9\ub2c8\ub2e4.<\/p>\n<p>\uc911\uc99d\uadfc\ubb34\ub825\uc99d \uce58\ub8cc\uc81c \uc2dc\uc7a5\uc740 2026\ub144 21.8\uc5b5 \ub2ec\ub7ec \uaddc\ubaa8\uc5d0\uc11c 2031\ub144\uae4c\uc9c0 31.7\uc5b5 \ub2ec\ub7ec\uc5d0 \uc774\ub97c \uac83\uc73c\ub85c \uc804\ub9dd\ub418\uba70, \uc608\uce21 \uae30\uac04 \ub3d9\uc548 \uc5f0\ud3c9\uade0 \uc131\uc7a5\ub960(CAGR) 7.82%\uc758 \uacac\uc870\ud55c \uc131\uc7a5\uc774 \uc608\uc0c1\ub429\ub2c8\ub2e4. \uc774\ub294 \uc9c8\ubcd1 \uc778\uc2dd \uac1c\uc120\uacfc \ud601\uc2e0\uc801\uc778 \uce58\ub8cc\uc81c \uac1c\ubc1c\uc5d0 \ud798\uc785\uc740 \uacb0\uacfc\uc785\ub2c8\ub2e4.<\/p>\n<p>\uc2dc\uc7a5 \uc131\uc7a5\uc758 \uc8fc\uc694 \ub3d9\ub825\uc740 \uc911\uc99d\uadfc\ubb34\ub825\uc99d \ubc1c\ubcd1\ub960 \uc99d\uac00 \ubc0f \uc870\uae30 \uc9c4\ub2e8 \ud655\ub300, \ubcf4\uccb4(Complement) \ubc0f FcRn(Neonatal Fc Receptor) \ud45c\uc801 \uc0dd\ubb3c\ud559\uc801 \uc81c\uc81c\uc758 \uc2b9\uc778 \uac00\uc18d\ud654\uc785\ub2c8\ub2e4. \ud76c\uadc0 \uc9c8\ud658 \uc778\uc13c\ud2f0\ube0c\uc640 \ud504\ub9ac\ubbf8\uc5c4 \uac00\uaca9 \ucc45\uc815 \uc804\ub7b5, \ubca4\ucc98 \ubc0f \ub300\ud615 \uc81c\uc57d\uc0ac \uac04\uc758 \uac70\ub798\ub97c \ud1b5\ud55c \uac15\ub825\ud55c \uc784\uc0c1 \ud30c\uc774\ud504\ub77c\uc778\ub3c4 \uc2dc\uc7a5 \ud65c\uc131\ud654\uc5d0 \uae30\uc5ec\ud569\ub2c8\ub2e4. \ud2b9\ud788, \uc790\uac00 \ud22c\uc5ec\ud615 \ud53c\ud558(SC) \uc0dd\ubb3c\ud559\uc801 \uc81c\uc81c(EMA \ubc0f FDA \uc2b9\uc778)\ub294 \uce58\ub8cc \uc21c\uc751\ub3c4\ub97c 89%\uae4c\uc9c0 \ub192\uc774\uace0 \ud658\uc790 \ud3b8\uc758\uc131 \ubc0f \ubcf4\ud5d8\uc0ac\uc758 \ube44\uc6a9 \ud6a8\uc728\uc131\uc744 \uac1c\uc120\ud569\ub2c8\ub2e4. \ub610\ud55c, AI \uae30\ubc18 \uadfc\uc804\ub3c4 \ubd84\uc11d \uae30\uc220\uc740 \uc870\uae30 \uc9c4\ub2e8 \ubc0f \uac1c\uc785\uc744 \uac00\ub2a5\ud558\uac8c \ud558\uc5ec \uce58\ub8cc \ud6a8\uacfc\ub97c \uadf9\ub300\ud654\ud569\ub2c8\ub2e4.<\/p>\n<p>\ubc18\uba74, \uc7a5\uae30 \uc0dd\ubb3c\ud559\uc801 \uce58\ub8cc\uc81c\uc758 \ub192\uc740 \ube44\uc6a9(\uc77c\ubd80 \uce58\ub8cc\uc81c\uc758 \uc5f0\uac04 \ube44\uc6a9\uc740 \uc57d 833,000\ub2ec\ub7ec), \uc2e0\ud765 \uacbd\uc81c\uad6d\uc758 \ub0ae\uc740 \uc9c8\ubcd1 \uc778\uc2dd, \ub2e8\uc77c\ud074\ub860\ud56d\uccb4(mAb)\uc758 \ucf5c\ub4dc\uccb4\uc778 \ubc0f \ubd84\uc11d \ud488\uc9c8 \ubcf4\uc99d \ubcf5\uc7a1\uc131\uc740 \uc2dc\uc7a5 \uc131\uc7a5\uc744 \uc800\ud574\ud569\ub2c8\ub2e4. \uc8fc\uc694 \ube14\ub85d\ubc84\uc2a4\ud130 \uc57d\ubb3c\uc778 \uc194\ub9ac\ub9ac\uc2a4(Soliris)\uc758 \ud2b9\ud5c8 \ub9cc\ub8cc(LOE) \ubc0f \ubc14\uc774\uc624\uc2dc\ubc00\ub7ec \uc9c4\uc785\uc5d0 \ub530\ub978 \uac00\uaca9 \ud558\ub77d \uc704\ud5d8 \ub610\ud55c \uc8fc\uc694 \uc81c\uc57d \uc694\uc778\uc785\ub2c8\ub2e4.<\/p>\n<p>\ubcf4\uace0\uc11c\ub294 \uc2dc\uc7a5\uc744 \ub2e4\uc591\ud55c \uae30\uc900\uc73c\ub85c \uc138\ubd84\ud654\ud558\uc5ec \ubd84\uc11d\ud569\ub2c8\ub2e4. \uce58\ub8cc\ubc95\ubcc4\ub85c\ub294 \uc57d\ubb3c \uce58\ub8cc, \uc2e0\uc18d \uba74\uc5ed \uc694\ubc95(\uc815\ub9e5 \uba74\uc5ed\uae00\ub85c\ubd88\ub9b0(IVIg), \ud608\uc7a5 \uad50\ud658\uc220), \uc720\uc804\uc790 \ubc0f \uc138\ud3ec \uce58\ub8cc\ubc95, \uae30\ud0c0 \uc2e0\ud765 \uce58\ub8cc\ubc95\uc73c\ub85c \ub098\ub269\ub2c8\ub2e4. \ud2b9\ud788, CAR-T \ubc0f \ud154\ub9ac\ud0c0\uc2dc\uc149\ud2b8(telitacicept)\uc640 \uac19\uc740 \uc720\uc804\uc790 \ubc0f \uc138\ud3ec \uce58\ub8cc\ubc95\uc740 \ub192\uc740 \ubc18\uc751\ub960\ub85c 9.41%\uc758 \uac00\uc7a5 \ube60\ub978 \uc5f0\ud3c9\uade0 \uc131\uc7a5\ub960\uc744 \uae30\ub85d\ud560 \uac83\uc73c\ub85c \uc608\uc0c1\ub429\ub2c8\ub2e4. \ud22c\uc5ec \uacbd\ub85c\ubcc4\ub85c\ub294 \uacbd\uad6c, \uc815\ub9e5 \uc8fc\uc0ac \uc678\uc5d0 \uc790\uac00 \ud22c\uc5ec\uac00 \uac00\ub2a5\ud55c \ud53c\ud558 \uc8fc\uc0ac \ubc29\uc2dd\uc774 \uc778\uae30\ub97c \uc5bb\uace0 \uc788\uc2b5\ub2c8\ub2e4. \uc57d\ubb3c \ubd84\ub958\ub294 \ucf5c\ub9b0\uc5d0\uc2a4\ud14c\ub77c\uc81c \uc5b5\uc81c\uc81c, \ucf54\ub974\ud2f0\ucf54\uc2a4\ud14c\ub85c\uc774\ub4dc \ubc0f \uae30\ud0c0 \uba74\uc5ed\uc5b5\uc81c\uc81c, \ub2e8\uc77c\ud074\ub860\ud56d\uccb4, \ubcf4\uccb4 \uc5b5\uc81c\uc81c, FcRn \uae38\ud56d\uc81c \ub4f1\uc73c\ub85c \uad6c\uc131\ub429\ub2c8\ub2e4. \ucd5c\uc885 \uc0ac\uc6a9\uc790 \uce21\uba74\uc5d0\uc11c\ub294 \ubcd1\uc6d0, \uc804\ubb38 \uc2e0\uacbd\uacfc \ud074\ub9ac\ub2c9, \uc7ac\ud0dd \uce58\ub8cc \ud658\uacbd, \uc678\ub798 \uc218\uc220 \uc13c\ud130 \ub4f1\uc774 \ud3ec\ud568\ub429\ub2c8\ub2e4. \uc9c0\uc5ed\ubcc4 \ubd84\uc11d\uc5d0\uc11c\ub294 \ubd81\ubbf8, \uc720\ub7fd, \uc544\uc2dc\uc544-\ud0dc\ud3c9\uc591, \uc911\ub3d9 \ubc0f \uc544\ud504\ub9ac\uce74, \ub0a8\ubbf8\ub97c \ub2e4\ub8e8\uba70, \uc544\uc2dc\uc544-\ud0dc\ud3c9\uc591 \uc9c0\uc5ed\uc740 PMDA(\uc77c\ubcf8) \ubc0f NMPA(\uc911\uad6d)\uc758 \uc2e0\uc18d\ud55c \uac80\ud1a0 \uc808\ucc28 \ub355\ubd84\uc5d0 9.46%\uc758 \uac00\uc7a5 \ub192\uc740 \uc131\uc7a5 \uc7a0\uc7ac\ub825\uc744 \ubcf4\uc774\uc9c0\ub9cc, \uce58\ub8cc\uc81c \uc811\uadfc\uc131 \ubc0f \uacbd\uc81c\uc131 \ubb38\uc81c\ub294 \uc5ec\uc804\ud788 \uacfc\uc81c\ub85c \uc9c0\uc801\ub429\ub2c8\ub2e4.<\/p>\n<p>\uacbd\uc7c1 \ud658\uacbd \ubd84\uc11d \uc139\uc158\uc5d0\uc11c\ub294 \uc2dc\uc7a5 \uc9d1\uc911\ub3c4, \uc8fc\uc694 \uae30\uc5c5\ub4e4\uc758 \uc2dc\uc7a5 \uc810\uc720\uc728 \ubd84\uc11d, \uadf8\ub9ac\uace0 AstraZeneca, argenx SE, UCB Pharma, Johnson &#038; Johnson (Janssen), Novartis AG \ub4f1 \uae00\ub85c\ubc8c \uc8fc\uc694 \uc81c\uc57d\uc0ac\ub4e4\uc758 \uc0c1\uc138\ud55c \uae30\uc5c5 \ud504\ub85c\ud544(\uae00\ub85c\ubc8c \ubc0f \uc2dc\uc7a5 \uc218\uc900 \uac1c\uc694, \ud575\uc2ec \ubd80\ubb38, \uc7ac\ubb34 \uc815\ubcf4, \uc804\ub7b5\uc801 \uc815\ubcf4, \uc2dc\uc7a5 \uc21c\uc704\/\uc810\uc720\uc728, \uc81c\ud488 \ubc0f \uc11c\ube44\uc2a4, \ucd5c\uadfc \uac1c\ubc1c \uc0ac\ud56d \ud3ec\ud568)\uc744 \uc81c\uacf5\ud569\ub2c8\ub2e4.<\/p>\n<p>\ubcf8 \ubcf4\uace0\uc11c\ub294 \uc911\uc99d\uadfc\ubb34\ub825\uc99d \uce58\ub8cc\uc81c \uc2dc\uc7a5\uc758 \ud604\uc7ac \ub3d9\ud5a5\uacfc \ubbf8\ub798 \uc804\ub9dd\uc744 \uc885\ud569\uc801\uc73c\ub85c \uc81c\uc2dc\ud558\uba70, \ubbf8\ucda9\uc871 \uc758\ub8cc \uc218\uc694(unmet need) \ubc0f \uc0c8\ub85c\uc6b4 \uae30\ud68c \uc601\uc5ed\uc5d0 \ub300\ud55c \uc2ec\uce35 \ud3c9\uac00\ub97c \ud1b5\ud574 \uc2dc\uc7a5 \ucc38\uc5ec\uc790\ub4e4\uc774 \ud6a8\uacfc\uc801\uc778 \uc804\ub7b5\uc744 \uc218\ub9bd\ud558\uace0 \uc9c0\uc18d \uac00\ub2a5\ud55c \uc131\uc7a5\uc744 \ub2ec\uc131\ud560 \uc218 \uc788\ub3c4\ub85d \uadc0\uc911\ud55c \ud1b5\ucc30\ub825\uc744 \uc81c\uacf5\ud569\ub2c8\ub2e4.<\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"closed","ping_status":"","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[1],"tags":[],"class_list":["post-41748","post","type-post","status-publish","format-standard","hentry","category-market-reports"],"_links":{"self":[{"href":"https:\/\/www.globalresearch.co.kr\/insight\/wp-json\/wp\/v2\/posts\/41748"}],"collection":[{"href":"https:\/\/www.globalresearch.co.kr\/insight\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.globalresearch.co.kr\/insight\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.globalresearch.co.kr\/insight\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.globalresearch.co.kr\/insight\/wp-json\/wp\/v2\/comments?post=41748"}],"version-history":[{"count":0,"href":"https:\/\/www.globalresearch.co.kr\/insight\/wp-json\/wp\/v2\/posts\/41748\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.globalresearch.co.kr\/insight\/wp-json\/wp\/v2\/media?parent=41748"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.globalresearch.co.kr\/insight\/wp-json\/wp\/v2\/categories?post=41748"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.globalresearch.co.kr\/insight\/wp-json\/wp\/v2\/tags?post=41748"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}